glp 1 approved for heart disease Can GLP-1 Drugs protection in Autoimmune Disease? Updated evidence on cardiovascular and

Some patients experience reduced appetite or changes in digestion due to delayed gastric emptying

[173] In the STEP-HFpEF trial including people with obesity and heart failure with preserved ejection fraction, weight loss was associated with improvements in heart failure symptoms and functional capacity

PlexusDx works with licensed compounding pharmacies to ensure medications are prescribed safely, especially for patients with complex medical histories

While short-term administration of GLP-1RAs have been associated with a transient increase in basal heart rate, long-term therapy contributes to sustained reductions in blood pressure, which may enhance renal outcomes by mitigating hyperfiltration and endothelial dysfunctions